Arcadia Biosciences, Inc. — Form D

Arcadia Biosciences, Inc. of DALLAS, TX, a company, filed a Form D exempt-offering notice with the SEC on 2009-11-25. The offering totals $12.0M, of which $2.4M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (39)

Showing 25 of 39 people.

NameRoleLocation
David CollierDirectorSunnyvale, CA
James ReisDirectorDallas, TX
Jonathan ThatcherDirectorPhoenix, AZ
Mark WongDirectorColumbus, OH
Steven BrandweinExecutive OfficerPhoenix, AZ
Eric ReyExecutive OfficerSeattle, WA
Amy YoderRelated PersonDallas, TX
Kevin ComcowichRelated PersonDallas, TX
Kevin T ComcowichDirectorDavis, CA
Albert D BollesDirectorDavis, CA
Lilian Shackelford MurrayDirectorDallas, TX
Lilian Shackelford MurrayRelated PersonDallas, TX
Gregory D WallerDirectorDallas, TX
Gregory D WallerRelated PersonDallas, TX
Amy D YoderDirectorDavis, CA
Matthew T PlavanDirectorDavis, CA
Matthew T PlavanExecutive OfficerDavis, CA
Pam T HaleyExecutive OfficerDavis, CA
Uday T GargDirectorDavis, CA
Rajendra T KetkarDirectorDavis, CA
Rajendra T KetkarExecutive OfficerDavis, CA
Eric T RayDirectorDavis, CA
Uday J GargDirectorCyber City, Ebene, O4
Darby J ShuppDirectorPhoenix, AZ
Steven J BrandweinDirectorPhoenix, AZ

Other filings by this issuer (6)

FiledFormOfferingSold
2026-06-26D$11.4M$4.0M
2026-01-27D$6.0M$2.1M
2021-02-16D$25.0M$25.0M
2018-04-11D$10.0M$10.0M
2014-04-25D$35.5M$18.9M
2009-08-04D$15.2M$15.2M

More